LifeVantage (LFVN) Set to Announce Quarterly Earnings on Thursday

LifeVantage (NASDAQ:LFVN) will be releasing its earnings data after the market closes on Thursday, May 2nd. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

LifeVantage (NASDAQ:LFVN) last released its earnings results on Tuesday, January 30th. The company reported $0.10 EPS for the quarter. LifeVantage had a net margin of 1.40% and a return on equity of 19.96%. The firm had revenue of $51.62 million for the quarter.

LifeVantage Stock Performance

LFVN stock opened at $6.17 on Thursday. LifeVantage has a one year low of $3.04 and a one year high of $8.69. The company’s fifty day moving average price is $6.59 and its 200-day moving average price is $6.42. The company has a market capitalization of $79.40 million, a PE ratio of 26.83 and a beta of 0.78.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.